Clinical trials data
Trail Making Test in brain injury and concussion trials: 115 registered studies
Every registered brain injury and concussion study on ClinicalTrials.gov that names the Trail Making Test in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered brain injury and concussion studies name it in an outcome measure
- 115
- Name it in a primary outcome, 38%
- 44 of 115
Tests named in the same studies
- 1
Verbal Fluency48 studies, 24 as a primary outcome
- 2
Verbal Learning46 studies, 20 as a primary outcome
- 3
Digit Span Test39 studies, 14 as a primary outcome
- 4
Stroop Color-Word Test26 studies, 14 as a primary outcome
- 5
Symbol Coding20 studies, 5 as a primary outcome
- 6
Category Fluency13 studies, 9 as a primary outcome
- 7
Paced Visual Serial Addition Test12 studies, 9 as a primary outcome
- 8
Letter-Number Sequencing Task12 studies, 5 as a primary outcome
- 9
Continuous Performance Test12 studies, 4 as a primary outcome
- 10
Task Switching Test12 studies, 4 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 1 | 0 |
| 2006 | 0 | 0 |
| 2007 | 2 | 1 |
| 2008 | 0 | 0 |
| 2009 | 4 | 1 |
| 2010 | 2 | 1 |
| 2011 | 5 | 2 |
| 2012 | 2 | 0 |
| 2013 | 6 | 3 |
| 2014 | 9 | 2 |
| 2015 | 4 | 2 |
| 2016 | 7 | 3 |
| 2017 | 11 | 2 |
| 2018 | 5 | 3 |
| 2019 | 5 | 3 |
| 2020 | 7 | 4 |
| 2021 | 8 | 4 |
| 2022 | 5 | 1 |
| 2023 | 9 | 4 |
| 2024 | 6 | 3 |
| 2025 | 9 | 4 |
| 2026 | 6 | 1 |
Phases and study sizes
By phase
- Early phase 11 studies, 0 as a primary outcome
- Phase 13 studies, 0 as a primary outcome
- Phase 1/21 studies, 0 as a primary outcome
- Phase 210 studies, 4 as a primary outcome
- Phase 34 studies, 1 as a primary outcome
- Phase 42 studies, 0 as a primary outcome
- Not applicable75 studies, 32 as a primary outcome
- Observational19 studies, 7 as a primary outcome
Participants per study
- Phase 247 median, 42 to 71
- Not applicable38 median, 21 to 77
- Observational117 median, 43 to 209
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Phase 2 | 10 | 47 | 42 to 71 |
| Not applicable | 74 | 38 | 21 to 77 |
| Observational | 18 | 117 | 43 to 209 |
When brain injury and concussion trials measure it
Latest time point of each outcome
- Within a day15 outcomes, 5 as a primary outcome
- Up to 4 weeks21 outcomes, 10 as a primary outcome
- 1 to 3 months40 outcomes, 15 as a primary outcome
- 3 to 6 months19 outcomes, 8 as a primary outcome
- 6 to 12 months11 outcomes, 4 as a primary outcome
- 1 to 2 years2 outcomes, 0 as a primary outcome
- Over 2 years1 outcomes, 0 as a primary outcome
- No duration given6 outcomes, 2 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
109 of the 115 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting24 studies, 8 as a primary outcome
- Not yet recruiting3 studies, 0 as a primary outcome
- Active, not recruiting1 studies, 0 as a primary outcome
- Completed58 studies, 23 as a primary outcome
- Stopped early12 studies, 4 as a primary outcome
- Status unknown17 studies, 9 as a primary outcome
What they test
- Behavioral38 studies, 17 as a primary outcome
- Drug14 studies, 3 as a primary outcome
- Device29 studies, 12 as a primary outcome
- Dietary supplement1 studies, 0 as a primary outcome
- Procedure7 studies, 1 as a primary outcome
- Diagnostic test3 studies, 3 as a primary outcome
- Biological3 studies, 1 as a primary outcome
- Combination product1 studies, 0 as a primary outcome
- Other28 studies, 14 as a primary outcome
- None given9 studies, 1 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States66 studies, 24 as a primary outcome
- Norway7 studies, 0 as a primary outcome
- France6 studies, 0 as a primary outcome
- Canada4 studies, 2 as a primary outcome
- Italy4 studies, 2 as a primary outcome
- Netherlands4 studies, 1 as a primary outcome
- Spain4 studies, 2 as a primary outcome
- Denmark3 studies, 1 as a primary outcome
- Sweden3 studies, 1 as a primary outcome
- Brazil2 studies, 2 as a primary outcome
- China2 studies, 1 as a primary outcome
- Finland2 studies, 1 as a primary outcome
26 countries in all. A study with sites in several counts in each; 9 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed brain injury and concussion studies that name the Trail Making Test: 26 of 58, 45%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed brain injury and concussion studies that name the Trail Making Test | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 7, 12% | 776, 10% |
| Results on ClinicalTrials.gov only | 10, 17% | 1,139, 14% |
| A results paper only | 9, 16% | 1,711, 22% |
| Neither | 32, 55% | 4,327, 54% |
The 115 studies
115 studies match. 44 name the Trail Making Test in a primary outcome. Median size 50 participants. Median time to the primary outcome: 11 weeks.
Loading 115 studies; the filters turn on when they arrive.
2026 is partly planned starts. Not shown: 2 planned to start after 2026.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 1 | 0 |
| 2006 | 0 | 0 |
| 2007 | 2 | 1 |
| 2008 | 0 | 0 |
| 2009 | 4 | 1 |
| 2010 | 2 | 1 |
| 2011 | 5 | 2 |
| 2012 | 2 | 0 |
| 2013 | 6 | 3 |
| 2014 | 9 | 2 |
| 2015 | 4 | 2 |
| 2016 | 7 | 3 |
| 2017 | 11 | 2 |
| 2018 | 5 | 3 |
| 2019 | 5 | 3 |
| 2020 | 7 | 4 |
| 2021 | 8 | 4 |
| 2022 | 5 | 1 |
| 2023 | 9 | 4 |
| 2024 | 6 | 3 |
| 2025 | 9 | 4 |
| 2026 | 6 | 1 |
Library tests named most
Largest condition groups
Phases
Participants
Lead sponsor: industry 5, NIH 2, other 108. Interventional 96, observational 19.
As a primary outcomeSecondary or other outcomeThe Trail Making Test
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07730099 | Start2027 | PhaseNot applicable | ConditionsBrain injury and concussion | Participants40 | Lead sponsorIndustry | StatusNot yet recruiting | Library tests named
|
| NCT07557615 | Start2027 | PhaseEarly phase 1 | ConditionsBrain injury and concussion | Participants50 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07431320 | Start2026 | PhaseNot applicable | ConditionsBrain injury and concussion, Healthy volunteers | Participants100 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07428980 | Start2026 | PhaseNot applicable | ConditionsBrain injury and concussion | Participants7 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07413562 | Start2025 | PhaseNot applicable | ConditionsBrain injury and concussion | Participants30 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07378592 | Start2025 | PhaseNot applicable | ConditionsBrain injury and concussion | Participants50 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07345481 | Start2026 | PhaseObservational | ConditionsStroke, Brain injury and concussion | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07190365 | Start2026 | PhaseNot applicable | ConditionsBrain injury and concussion | Participants80 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07050173 | Start2026 | PhasePhase 1 | ConditionsBrain injury and concussion | Participants30 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07025317 | Start2024 | PhaseNot applicable | ConditionsBrain injury and concussion | Participants200 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06989970 | Start2026 | PhaseNot applicable | ConditionsBrain injury and concussion | Participants20 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT06956404 | Start2025 | PhaseNot applicable | ConditionsBrain injury and concussion | Participants70 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06923683 | Start2025 | PhaseNot applicable | ConditionsBrain injury and concussion | Participants8 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06920784 | Start2024 | PhaseNot applicable | ConditionsBrain injury and concussion | Participants50 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06848140 | Start2025 | PhaseNot applicable | ConditionsBrain injury and concussion | Participants24 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06840808 | Start2024 | PhaseNot applicable | ConditionsBrain injury and concussion | Participants14 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06800040 | Start2025 | PhaseNot applicable | ConditionsStroke, Brain injury and concussion | Participants20 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06749197 | Start2025 | PhaseNot applicable | ConditionsStroke, Brain injury and concussion, ADHD | Participants30 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06604000 | Start2023 | PhaseNot applicable | ConditionsBrain injury and concussion | Participants116 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06589362 | Start2024 | PhaseNot applicable | ConditionsBrain injury and concussion | Participants60 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06562127 | Start2025 | PhaseNot applicable | ConditionsBrain injury and concussion | Participants120 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06494592 | Start2023 | PhaseNot applicable | ConditionsBrain injury and concussion | Participants37 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06480838 | Start2023 | PhaseObservational | ConditionsBrain injury and concussion | Participants130 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06474871 | Start2024 | PhaseNot applicable | ConditionsBrain injury and concussion | Participants28 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06380985 | Start2024 | PhaseNot applicable | ConditionsBrain injury and concussion, Substance use and addiction | ParticipantsNot given | Lead sponsorOther | StatusStopped early | Library tests named
|
Questions, answered from the data
How many brain injury and concussion trials use the Trail Making Test?
115 registered brain injury and concussion studies on ClinicalTrials.gov name it in an outcome measure, 44 of them in a primary outcome: 26% of the condition's 444 studies with a cognitive outcome, against 14% of all of them. It is the test brain injury and concussion trials name most.
Which tests do brain injury and concussion trials use with the Trail Making Test?
Verbal Fluency (48 studies), Verbal Learning (46 studies) and the Digit Span Test (39 studies).
How many participants do phase 2 brain injury and concussion trials that use the Trail Making Test enroll?
Half of the phase 2 studies that name it enroll 47 participants or fewer, and the middle half enroll 42 to 71. 10 of them give a size.
When do brain injury and concussion trials measure the Trail Making Test?
Half of the primary outcomes that name the Trail Making Test are measured within 11 weeks of the start, and the middle half from 1 week to 5 months. 42 primary outcomes give a duration.
How many completed brain injury and concussion trials that use the Trail Making Test have reported results?
26 of the 58 completed studies that name it, 45%, have reported results: 17 posted them on ClinicalTrials.gov, 16 have a results paper linked to the registry record, and 7 did both. The other 32 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
The census counts Trail Making Test A and Trail Making Test B as one test family, so this page counts their studies together.
Run the Trail Making Test in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.